AMSBIO Expands US Operations
News Apr 23, 2014
AMSBIO has announced the opening of a new North American headquarters with executive management facilities in Cambridge, MA for its US subsidiary - AMSBIO LLC.
Commenting on this strategic move, Alex Sim (President, AMSBIO) said “The US is the single largest market for our stem cell and regenerative medicine, glycobiology enzymes / substrates and tissue derived products. Drawing upon our in-depth expertise in extracellular matrices we are able to also provide elegant solutions for studying cell motility, migration, invasion and proliferation”.
He added “Our North American customer base has been growing strongly over recent years. From the new East Coast facility we will provide local informed service and support as well as next day delivery of a comprehensive range of enabling technology products to help improve the productivity of our US customers”.
RELATED ARTICLES
Olfactory Receptors Not Just For Smell Perception
NewsNovel cellular functions of olfactory receptors highlighted
READ MORE
Why Internal Scars Won't Stop Growing
NewsNormal scar tissue forms to heal an internal wound and quietly retreats when the job is done. But in many common diseases the scar tissue goes rogue and strangles vital organs. These diseases are largely untreatable and ultimately fatal. A new study has newly identified a trigger of some fibrotic diseases and an experimental compound to treat it.
New Approach Sheds Light on the Effects of Anti-Cancer Drugs
NewsA new approach established at the University of Zurich sheds light on the effects of anti-cancer drugs and the defense mechanisms of cancer cells. The method makes it possible to quickly test various drugs and treatment combinations at the cellular level.
READ MORETo personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free
LOGIN SUBSCRIBE FOR FREE
